SDS Biotech K.K. Reports Consolidated Earnings Results for the Nine Months Ended September 30, 2015; Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2016; Provides Dividend Guidance for the Year Ended March 31, 2016; Announces Change in Fiscal Year from December 31 to March 31
The company provided consolidated earnings guidance for the fiscal year ending March 31, 2016. For the year, the company expects to report net sales of ¥20,880 million, operating income of ¥2,170 million, ordinary income of ¥1,800 million and net income of ¥1,100 million or ¥140.46 per share.
The company provided dividend guidance for the year ended March 31, 2016. For the year the company expects to pay dividend of ¥15.00 as compared to ¥10.00 last year.
In line with the change of fiscal year-end (last day of a fiscal year) from December 31 to March 31, the fiscal year under review consists of 15 months from January 1, 2015 to March 31, 2016.